Stability of measurements of biomarkers of oxidative stress in blood over 36 hours

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 8, 2004, Pages 1399-1402

  Wu, Tianying ^a,b   Rifai, Nader ^b   Roberts II, L Jackson ^d   Willett, Walter C ^a,c   Rimm, Eric B ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUORESCENT DYE; ICE; ISOPROSTANE; ISOPROSTANE F2; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD STORAGE; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FLUORESCENCE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MASS SPECTROMETRY; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN STABILITY; SPECTROFLUOROMETRY;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PRESERVATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; F2-ISOPROSTANES; FEMALE; HUMANS; ICE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 4043107956     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Meraji S, Abuja PM, Hayn M, et al. Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. Atherosclerosis 2000;150:403-12.
2. Singh V, Ghalaut PS, Kharb S, Singh GP. Plasma concentrations of lipid peroxidation products in children with acute leukemia. Indian J Med Sci 2001;55:215-7.
3. Skrzydlewska E, Stankiewicz A, Sulkowska M, Sulkowski S, Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health A 2001;64:213-22.
4. Shimizu I, Inoue H, Yano M, et al. Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 2001;21:342-9.
5. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000;102:840-5.
6. Cracowski JL, Tremel F, Marpeau C, et al. Increased formation of F[2]-isoprostanes in patients with severe heart failure. Heart 2000;84:439-40.
7. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000;35:967-74.
8. Pratico D, Clark CM, Lee VM, Trojanowski JQ, Rokach J, FitzGerald GA. Increased 8,12-iso-iPF2α-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol 2000;48:809-12.
9. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-203.
10. Mezzetti A, Zuliani G, Romano F, et al. The Associazione Medica Sabin. Vitamin E and lipid peroxide plasma levels predict the risk of cardiovascular events in a group of healthy very old people. J Am Geriatr Soc 2001;49:533-7.
11. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon Press; 1999.
12. Voziyan PA, Metz TO, Baynes JW, Hudson BG. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 2002;277:3397-403.
13. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82:4245-9.
14. Roberts LJ II, Montine TJ, Markesbery WR, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosa-hexaenoic acid. J Biol Chem 1998;273:13605-12.
15. Hecht SS, McIntee EJ, Wang M. New DNA adducts of crotonaldehyde and acetaldehyde. Toxicology 2001;166:31-6.
16. Miyata T, Oda O, Inagi R, et al. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993;92:1243-52.
17. McCance DR, Dyer DG, Dunn JA, et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993;91:2470-8.
18. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993;57 Suppl 5:715S-24S.
19. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28:504-8.
20. Awad JA, Morrow JD, Takahashi K, Roberts LJ II. Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J Biol Chem 1993;268:4161-9.
21. Voutilainen S, Morrow JD, Roberts LJ II, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999;19:1263-6.
22. 2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol 1994;233:163-74.
23. Shimasaki H. Assay of fluorescent lipid peroxidation products. Methods Enzymol 1994;233:338-46.
24. Rosner B. Fundamentals of biostatistics. Pacific Grove (CA): Duxbury Press; 1999.
25. Kontush A, Beisiegel U. Measurement of oxidizability of blood plasma. Methods Enzymol 1999;299:35-49.
26. Pischon T, Hotamisligil GS, Rimm EB. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003;49:650-2.
27. Kurtz AJ, Lloyd RS. 1,N2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage. J Biol Chem 2003;278:5970-6.